Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
RESEARCH TOOLSreports
Holding DE:FME?
Track your performance easily
FME Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€32.51 - €46.20
Previous Close€43.88
Volume293.86K
Average Volume (3M)359.44K
Market Cap
€12.88B
Enterprise Value€20.43B
Total Cash (Recent Filing)$1.56B
Total Debt (Recent Filing)$7.90B
Price to Earnings (P/E)19.5
Beta0.88
Next Earnings
Feb 25, 2025EPS Estimate
€0.9Last Dividend Ex-Date
May 17, 2024Dividend Yield2.67%
Share Statistics
EPS (TTM)2.25
Shares Outstanding293,413,449
10 Day Avg. Volume409,216
30 Day Avg. Volume359,438
Standard Deviation0.09
R-Squared0.12
Alpha-0.00122
Financial Highlights & Ratios
Price to Book (P/B)1.88
Price to Sales (P/S)0.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.07
Enterprise Value/Gross Profit4.15
Enterprise Value/Ebitda11.57
Forecast
1Y Price Target
€44.83Price Target Upside2.34% Upside
Rating ConsensusHold
Number of Analyst Covering15
Fresenius Medical Care AG & Co. KGaA News
Bulls Say, Bears Say
Bulls Say
Financial StrategyFresenius Medical Care is prioritizing cash generation to support business growth, reduce debt, and potentially increase shareholder returns, reflecting a strong financial strategy.
Market PositionThe company is the only one with FDA-approved technology for high-volume hemodiafiltration, positioning it advantageously in the market.
Technological AdvancementsThe introduction of new technology, such as the 5008X machine, is expected to support clinic utilization and improve patient care, which can enhance operational efficiency.
Bears Say
Financial PerformanceManagement cut their target of same treatment volume growth and now expects 0-0.5% for FY24.
Market ChallengesThere is continued caution on the dialysis market, which is seen as structurally challenged and at risk of reimbursement changes.
Valuation ConcernsThe stock currently trades on c15x P/E 2024 (c40% discount to sector) which we see as still demanding for a c2% sales CAGR 2024-26 vs our sector c7%.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
19.55% Mutual Funds
<0.01% Other Institutional Investors
73.70% Public Companies and
Individual Investors
FME FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest stock price was €32.51 and its highest was €46.20 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Currently, no data Available
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is Feb 25, 2025 which is in 65 days.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Nov 05, 2024. The company reported €0.82 earnings per share for the quarter, beating the consensus estimate of €0.711 by €0.109.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Undervalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA pays a Annually dividend of €1.19 which represents an annual dividend yield of 2.67%. See more information on Fresenius Medical Care AG & Co. KGaA dividends here
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is €0.9.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €0.82 in its last earnings report, beating expectations of €0.711. Following the earnings report the stock price went up 1.122%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:FME
---
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.82%
12-Months-Change
Fundamentals
Return on Equity
4.77%
Trailing 12-Months
Asset Growth
-8.77%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
---
FME Stock 12 Month Forecast
Average Price Target
€44.83
▲(2.34% Upside)
Technical Analysis
Hikma Pharmaceuticals
―
Genus plc
―
PureTech Health
―
Fresenius Medical Care AG & Co. KGaA
―
Best Analysts Covering FME
1 Year
1 Year Success Rate
14/19 ratings generated profit
1 Year Average Return
+11.90%
reiterated a buy rating 16 days ago
Copying Victoria Lambert's trades and holding each position for 1 Year would result in 73.68% of your transactions generating a profit, with an average return of +11.90% per trade.
---